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Abstract
A diet with restricted energy content reduces the occurrence of cancer in animal experi-
ments. It is not known if the underlying mechanism also exists in human beings. To deter-
mine whether cancer incidence is reduced among patients with anorexia nervosa who tend
to have a low intake of energy, we carried out a retrospective cohort study of 22 654 women
and 1678 men diagnosed with anorexia nervosa at ages 10-50 years during 1968-2010 ac-
cording to National Hospital Registers in Sweden, Denmark and Finland. The comparison
group consisted of randomly selected persons from population registers who were similar to
the anorexia nervosa patients in respect to sex, year of birth and place of residence. Pa-
tients and population comparisons were followed for cancer by linkage to Cancer Regis-
tries. Incidence rate ratios (IRR) were estimated using Poisson models. In total, 366 cases
of cancer (excluding non-melanoma skin cancer) were seen among women with anorexia
nervosa, and the IRR for all cancer sites was 0.97 (95% CI = 0.87-1.08) adjusted for age,
parity and age at first child. There were 76 breast cancers corresponding to an adjusted IRR
of 0.61 (95% CI = 0.49-0.77). Significantly increased IRRs were observed for esophageal,
lung, and liver cancer. Among men with anorexia nervosa, there were 23 cases of cancer
(age-adjusted IRR = 1.08; 95% CI = 0.71-1.66). There seems to be no general reduction in
cancer occurrence among patients with anorexia nervosa, giving little support to the energy
restriction hypothesis.
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Introduction
Energy restriction without malnutrition is the most potent known dietary intervention to con-
sistently prevent cancer in animal experiments [1], but whether this observation can be extrap-
olated to human beings is currently unknown. Several studies have investigated the hypothesis
by exploring cancer incidence or mortality in human populations exposed to varying degrees
of energy restriction such as residents of Okinawa in Japan [2], Cubans exposed during the eco-
nomic crisis of 1991–95 [3], women exposed during World War II in Norway [4] and the
Netherlands [5, 6] and patients with anorexia nervosa from Denmark [7] and Sweden [8–10].
These studies have shown conflicting results.
Patients with anorexia nervosa experience a low intake of calories often for long periods of
their lives [11–13]. In a previous study of approximately 2000 female patients with anorexia
nervosa from Denmark a slight, non-significantly reduced risk of cancer was seen compared to
the Danish female background population [7]. A Swedish study including more than 7000
women with anorexia nervosa reported a significantly decreased risk of breast cancer on the
basis of seven observed cases with parous women having a particularly low risk [8]. A subse-
quent study with extended follow-up including 16 observed cases of breast cancer, showed that
parous women with early onset anorexia nervosa had a remarkably low risk of breast cancer
[9]. However, this finding was based on small numbers. The overall incidence of all types of
non-breast cancer resembled that of the general Swedish female population [10].
Anorexia nervosa is a mental disorder characterized by a variety of serious psychiatric and
somatic health problems. It may, however, serve as a model of energy restriction that may pro-
vide important knowledge about cancer. Most of the prior studies investigating the energy re-
striction hypothesis in human populations have focused on breast cancer. However, the animal
experiments suggest that other cancer types may be affected by energy restriction. Our large-




The present study is a register-based matched cohort study. Patients with anorexia nervosa
were identified in National Hospital Registries if discharged during 1973–2010 in Sweden,
1970–2009 in Denmark and 1969–2009 in Finland with the following International Classifica-
tion of Disease (ICD) codes: Swedish and Finnish ICD-8 = 306.50 (appetite disturbance), Dan-
ish ICD-8 = 306.50 (anorexia nervosa), Swedish ICD-9 = 307B (anorexia nervosa), Finnish
ICD-9 = 307A (anorexia nervosa), in all three countries ICD-10 = F50.0 (anorexia nervosa)
and ICD-10 = F50.1 (atypical anorexia nervosa). The ICD-8 code for appetite disturbance used
in Sweden (1973–86) and Finland (1969–1986) may have included other types of appetite dis-
turbances apart from anorexia nervosa such as bulimia. However, the majority is likely to have
been diagnosed with anorexia nervosa, since there was only a slight change in the number of
patients included in the study after the specific anorexia nervosa ICD-9 code was introduced in
1987 in Sweden and Finland. Also, a study including admissions to psychiatric hospitals in
Denmark, showed that among patients with appetite disturbances (Danish ICD-8 = 306.50–
59), 76% had anorexia nervosa (Danish ICD-8 = 306.50), 10% had other specified disturbances
of appetite (Danish ICD-8 = 306.58) and 13% had non-specified appetite disturbances (Danish
ICD-8 = 306.59)[14]. In Sweden [15] and Finland [16, 17], the Hospital Registers includes in-
formation from both psychiatric and somatic hospitals whereas in Denmark hospitalizations at
psychiatric hospitals have been included in a separate register dating back to 1970—the Central
Anorexia Nervosa and Cancer
PLOS ONE | DOI:10.1371/journal.pone.0128018 May 22, 2015 2 / 11
information-for-researchers) for researchers who
meet the criteria for access to confidential data.
Funding: This work was supported by the Danish
Council for Independent Research (grant number 11-
108395) (LM), the Swedish Society of Medicine
(grant numbers SLS-253101, SLS-230421) (FCP),
and the Stockholm County Council (grant numbers
20100328, 20130084) (AE). The funders had no role
in study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
Psychiatric Register [18]—which was also used to identify patients. Information on outpatient
visits is included in the Danish register from 1995 [19] and in the Finnish register from 1998.
Patients were included in the final cohort on condition that they were between ten and 50 years
at first hospital admission or outpatient visit. In total, 24 471 persons with anorexia nervosa
fulfilled the inclusion criteria.
From Population Registers in each of the three countries, we aimed at selecting ten compari-
sons per patient with anorexia nervosa of similar sex, birth year and place of residence (county
in Sweden and Finland, region in Denmark) at time of the first hospital contact for anorexia
nervosa, but otherwise randomly selected. For most of the anorexia nervosa patients, it was pos-
sible to select ten comparisons, and we ended up with a comparison cohort consisting of 244
108 persons. Vital and emigration status was obtained from these registers for all patients with
anorexia nervosa and for comparisons. We excluded 53 (0.2%) patients with anorexia nervosa
and 574 (0.2%) comparisons who had emigrated before entry as well as 12 (0.005%) compari-
sons who had disappeared before entry. Information on offspring among the Danish and Finn-
ish study participants were traced in the Population Registries in each of these countries, while
offspring among Swedish study participants were traced in the Swedish Fertility Register [20].
Follow-up for cancer
Patients with anorexia nervosa and population comparisons were linked to the Cancer Regis-
tries in each of the countries to identify all cancer diagnoses. Anorexia nervosa patients with
cancer (except non-melanoma skin cancer) before the first known hospitalization with the con-
dition were excluded (N = 84, 0.3%) as were comparisons with cancer before the date of an-
orexia in the patient (N = 704, 0.3%). After the above mentioned exclusions, two anorexia
nervosa patients had no comparisons, and 1569 comparisons had no matched anorexia nervosa
patients, and these persons were also left out of the final study cohorts. Follow-up for cancer
started on admission date of the first known hospital contact with anorexia nervosa (and the
corresponding date for the matched comparison) and continued until date of cancer diagnosis
(except non-melanoma skin cancer), death, emigration or end of study (31st December 2010 in
Sweden, 31st December 2011 in Denmark and 31st December 2009 in Finland (three more
years of follow-up data would have been available from the Finnish Cancer Registry, but the
study permission did not give right to use the data on cancer cases diagnosed after 2009)). Can-
cer sites were grouped into 1) sites convincingly related to BMI, 2) sites possibly related to BMI
and 3) other sites [21, 22]. Patients with anorexia and comparisons were followed for non-mel-
anoma skin cancer in a separate analysis where those with non-melanoma skin cancer before
entry were excluded.
Ethical statement
In Sweden, the study was approved by the Regional Ethical Review Board in Uppsala. In Den-
mark, the study was approved by the Data Protection Board and in Finland, by the National
Institute for Health and Welfare. Approvals from Ethical Committees are not needed for regis-
try-based research in Denmark and Finland. Written consent from study participants was not
obtained, since in all three countries this is not required for register-based studies that do not
involve contact with study participants or biological samples. Data on study participants was
anonymized and de-identified prior to analysis.
Statistical analyses
Poisson regression models were used to calculate incidence rate ratios (IRRs) of cancer com-
paring cancer incidence rates among patients with anorexia nervosa to rates among population
Anorexia Nervosa and Cancer
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comparisons with adjustment for running age (five-year groups), calendar-period (ten-year
groups), and country (Denmark, Sweden, Finland). Adjustment for calendar-year and country
did not change the estimates, so the final models only included running age. All analyses were
carried out for men and women separately. Analyses among female patients and comparisons
were also adjusted for age at first childbirth (continuous variable) and parity (nulliparous, one
child, two children, three children, and at least four children) with the variables being time depen-
dent. In the analyses stratified on parity, women who were nulliparous at first record of anorexia
nervosa contributed person-years to the nulliparous strata until birth of their first child, when
they started to contribute person-years to the parous strata, whereas women who had given birth
at first anorexia nervosa record contributed person-years to the parous strata from entry date.
Statistical analyses were performed using SAS version 9.1 (SAS Institute, Cary, NC, USA).
Results
A total of 24 332 patients with anorexia nervosa and 241 249 population comparisons were in-
cluded in the analyses with 37% from Sweden, 35% from Denmark and 29% from Finland. The
anorexia nervosa patients and comparisons were followed for 305 759 and 3 174 468 person-
years, respectively, and an average of 12.6 and 13.2 years, respectively. There were 22 654
(93%) females and 1678 (7%) males with anorexia nervosa (Table 1). The majority of both
Table 1. Characteristics of women andmen with anorexia nervosa identified in Hospital Registers in
Sweden, Denmark and Finland.
Women Men
Number % Number %
All patients with anorexia nervosa 22 654 100 1678 100
Country
Sweden 8272 37 632 38
Denmark 7945 35 530 32
Finland 6437 28 516 31
Age at ﬁrst admission with anorexia nervosa (years)
10–19 14 237 63 1145 68
20–29 6084 27 331 20
30–39 1633 7 134 8
40–50 700 3 68 4
Calendar-year at ﬁrst admission with anorexia nervosa
1968–79a 1671 7 190 11
1980–89 3851 17 365 22
1990–99 5812 26 372 22
2000–10b 11 320 50 751 45
Parity (at end of follow-up)
Nulliparous 14 432 64 - -
Parous
1 child 3031 13 - -
2 children 3298 15 - -
3 children 1332 6 - -
4 children or more 561 2 - -
a First admission date in Denmark in 1968, Sweden in 1970 and Finland in 1969.
b Last admission date in Denmark in 2009, Sweden in 2010 and Finland in 2009.
doi:10.1371/journal.pone.0128018.t001
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female (63%) and male (68%) patients were below age 20 years at first anorexia nervosa related
hospital contact. The number of patients increased by calendar-period; some of this increase
was due to adding outpatients in the Danish and Finnish Hospital Registers from 1995 and
1998, respectively.
In the combined cohort of female patients with anorexia nervosa, we identified a total of 366
cases of cancer excluding non-melanoma skin cancer, whereas we identified 4,263 cases among
population comparisons (Fig 1). The age-adjusted IRR was (0.97; 95% CI = 0.88–1.08). The
overall IRRs were quite similar in all three countries studied. Adjustment for parity and age at
first child did not change the IRR of all cancer sites combined (IRR = 0.97; 95% CI = 0.87–
1.08).
Among the female anorexia nervosa patients, the IRR of breast cancer was markedly de-
creased (IRR = 0.6; 95% CI = 0.5–0.8) on the basis of 76 observed cases (Table 2). A reduced
risk was also seen for other female cancers such as endometrial, ovarian, and cervical cancer al-
though only the IRR for cervical cancer was statistical significant. The IRRs of esophageal and
liver cancer were five-fold significantly increased with five and eight observed cases, respective-
ly. There was also an excess of lung cancer.
The IRR for female breast cancer associated with anorexia nervosa remained largely un-
changed after adjustment for parity and age at first child (IRR = 0.61; 95% CI = 0.49–0.77)
(Table 3). This 40% reduction was seen among women with anorexia nervosa from both Swe-
den and Denmark but not among those from Finland among whom only six cases of breast
cancer were observed. The IRR for breast cancer associated with anorexia varied little when
stratified on calendar-period, time between anorexia and cancer, age at cancer and age at an-
orexia. Among women with anorexia who were nulliparous, the IRR of breast cancer was 0.7
(95% CI = 0.5–1.0), while the IRR among those who were parous was 0.5 (95% CI = 0.4–0.7)
Fig 1. Incidence rate ratios of cancer among patients with anorexia nervosa. Age-adjusted incidence rate ratios (IRRs) and 95% confidence intervals
(CI) of all types of cancer except non-melanoma skin among women and men with anorexia nervosa from Sweden, Denmark and Finland compared to
randomly selected population comparisons. No = number.
doi:10.1371/journal.pone.0128018.g001
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Table 2. Age-adjusted incidence rate ratios (IRR) of selected types of cancer among women andmen with anorexia nervosa compared to random-
ly selected comparisons in Sweden, Denmark and Finland.
Women Men
















Sites related to BMI—
convincing evidencea
Esophagus 5b 12 5.1 1.8–
14.6
0 2 - -
Colorectum 26 265 1.2 0.8–
1.8
1 27 0.5 0.1–
3.7
Pancreas 6 42 1.8 0.8–
4.3
1 4 3.8 0.4–
34.3
Breast 76 1468 0.6 0.5–
0.8
0 1 - -
Endometrium 7 121 0.7 0.3–
1.5
- - - -
Kidney 3 34 1.0 0.3–
3.3






2 13 2.0 0.4–
8.7
0 2 - -
Ovary 9 183 0.6 0.3–
1.1
- - - -
Prostate - - - - 1 30 0.5 0.1–
3.4
Thyroid gland 11 130 0.9 0.5–
1.7
0 5 - -
Lymphoma and
hematopoietic
30 300 1.1 0.8–
1.6
7 35 2.2 1.0–
5.0
Other sites
Liver 8 18 5.2 2.3–
12.1
0 1 - -
Lung 29 222 1.6 1.1–
2.4
1 15 0.9 0.1–
6.8
Melanoma 41 396 1.1 0.8–
1.5
1 16 0.7 0.1–
5.5
Cervix 21 333 0.7 0.4–
1.0
- - - -




37 335 1.2 0.8–
1.7
7 35 2.3 1.0–
5.2
Other 55 391 1.6 1.2–
2.1




48 579 1.1 0.8–
1.5
5 36 1.1 0.8–
1.5
aAccording to Summary from World Cancer Research Fund [20] and Renehan AG et al. [21,22].
bThree cases of squamous cell carcinoma and two cases of adenocarcinoma.
cFollow-up for non-melanoma skin cancer was performed in a separate analysis.
doi:10.1371/journal.pone.0128018.t002
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(Table 3). Among women who had given birth and were 10–19 years at first admission with an-
orexia nervosa, the IRR associated with anorexia was 0.6 (95% CI = 0.3–1.0) (data not shown).
Amongmen with anorexia nervosa from all three countries combined, there were 23 cases
of cancer excluding non-melanoma skin cancer compared to 257 among population compari-
sons which gave a IRR close to 1.0 (Fig 1). No significantly decreased IRRs were found for any
of the specific sites of cancer investigated (Table 2). The IRRs for lymphoma and hematopoietic
cancer and for cancer in the brain and nervous system were significantly elevated.
Discussion
The overall cancer incidence among patients with anorexia nervosa from three Nordic
countries resembled that of population comparisons. A remarkably low risk of breast cancer
was seen among female patients. This low risk was not in particular confined to those with
Table 3. Incidence rate ratios (IRRs) for breast cancer among women with anorexia nervosa compared to randomly selected women in Sweden,
Denmark and Finland by country, calendar-period, time between anorexia and cancer, age at cancer and at anorexia and parity.
No. of breast cancers Age-adjusted Also adjusted for
parity and age at ﬁrst
childbirth
Characteristic Anorexia patients Population comparisons IRR 95% CI IRR 95% CI
All 76 1468 0.60 0.47–0.75 0.61 0.49–0.77
Country
Denmark 33 624 0.6 0.5–0.9 0.7 0.5–0.9
Sweden 37 686 0.6 0.4–0.8 0.6 0.4–0.9
Finland 6 158 1.1 0.9–1.3 1.0 0.9–1.2
Calendar-period at
anorexia
1969–1994 65 1298 0.6 0.5–0.8 0.6 0.5–0.8




0–4 4 113 0.4 0.1–1.0 0.4 0.1–1.0
5–9 11 153 0.8 0.4–1.5 0.8 0.4–1.5
10–19 27 507 0.6 0.4–0.9 0.6 0.4–0.9
20 or more 34 695 0.6 0.4–0.8 0.6 0.4–0.8
Age at cancer
(years)
10–44 33 534 0.6a 0.4–0.9 0.7a 0.5–1.0
45–54 32 601 0.6 a 0.4–0.9 0.7 a 0.5–1.0
55 or more 11 333 0.4 a 0.2–0.8 0.5 a 0.3–0.9
Age at anorexia
(years)
10–19 21 323 0.7 0.4–1.1 0.7 0.5–1.1
20–50 55 1145 0.6 0.4–0.7 0.6 0.4–0.8
Parity
Nulliparous 35 321 0.7 0.5–1.0 - -
Parous 41 1147 0.5 0.4–0.7 - -
a Not adjusted for age.
doi:10.1371/journal.pone.0128018.t003
Anorexia Nervosa and Cancer
PLOS ONE | DOI:10.1371/journal.pone.0128018 May 22, 2015 7 / 11
early-onset anorexia or to those having children. There were excesses of esophageal, lung, and
liver cancer among women with anorexia.
According to the energy restriction hypothesis that is based on observations in animal ex-
periments, a diet with reduced energy content but sufficient in nutrients would decrease cancer
incidence in general [1]. The sparse data on humans have not supported the hypothesis.
Among women from the Netherlands who had been exposed to the severe famine in 1944–45,
no indication of any excess or deficit of cancer in general was seen [5], while Israeli Jewish sur-
vivors of World War II had an increased risk of all sites of cancer [23]. In Cuba, where the per
capita energy intake decreased substantially during the severe economic crisis in 1991 to 1995,
a slight increase in cancer mortality rates for the Cuban population were observed during
1996–2010 [3]. Our results concerning overall cancer incidence among patients with anorexia
nervosa also provide no support to the energy restriction hypothesis as being relevant for can-
cer in general.
When we grouped the cancer sites according to their relationship with excess body fat [21,
22], we found no pattern of decreased risks associated with anorexia nervosa for cancer sites ei-
ther convincingly or possibly linked to excess body fat. However, among the sites convincingly
associated with excess body fat, a clear deficit was seen for breast cancer. An ecologic study of
Norwegian women showed that the incidence of breast cancer was lower than expected among
women who experienced puberty during World War II when food was restricted in certain
areas [24]. However, Dutch women who were severely exposed to the famine during 1944–45
had a higher risk of breast cancer than unexposed women [6]. The authors suggested that the
lack of consistency with the energy restriction hypothesis could be caused by the fact that these
women were exposed to a short-term transient energy restriction followed by abundance of en-
ergy intake as supported by some animal studies [6].
The only previous studies investigating cancer risk among patients with anorexia nervosa
are from Sweden [8–10] and Denmark [7], and data from these studies are part of the present
study. In one of the prior Swedish studies, a particularly low risk of breast cancer was found
among parous women who were 10–24 years at first admission for anorexia nervosa [9]. We
did not find a more markedly decreased risk among the youngest women using the age range
10–19 years to capture women having the first admission for anorexia nervosa during the peri-
od of growth. Parous women in our study tended to have slightly lower risk than nulliparous
women, but we could not confirm that parous women with early onset anorexia nervosa had a
particularly low risk. The markedly low risk of breast cancer among women with anorexia ner-
vosa could be caused by other patient characteristics besides a low intake of energy. High level
of physical activity could be one of these. It could also be a combined effect of extensive train-
ing and low energy intake that disrupts the hypothalamic signals to the pituitary consequently
leading to reduced level of estrogen, amenorrhea and anovulation [25]. Anovulation reduces
the risk of ovarian cancer [26] and may explain the borderline significant deficit seen for this
cancer in our study. The decreased risk of cervical cancer could be the result of fewer HPV in-
fections due to decreased sexual activity among women with anorexia nervosa compared to the
background population [27].
We found excess risks of esophageal and liver cancer among women with anorexia nervosa
compared to the random sample of women. Excessive alcohol intake is a risk factor for both
types of cancer [28, 29] and alcohol abuse or dependence have been reported to occur more fre-
quently among patients with anorexia nervosa [30]. Also, Barrett’s esophagus that may prog-
ress to adenocarcinoma of the esophagus [31] has been reported in patients with bulimia [32],
and compensatory behaviors such as self-induced vomiting, typically seen in bulimia, are
known to coexist with anorexia nervosa in some cases. Alternative explanations for the excess
of liver cancer may be linked to hepatocellular damage in anorexia nervosa that is indicated by
Anorexia Nervosa and Cancer
PLOS ONE | DOI:10.1371/journal.pone.0128018 May 22, 2015 8 / 11
abnormal liver functions tests found in some anorexia nervosa patients [33]. The excess of lung
cancers could be due to higher prevalence of smokers among patients with some types of an-
orexia nervosa [34]. Smoking habits could also contribute to the increased risk of esophageal
cancer [28].
The present study has the advantage of including more than 20 000 female patients with
anorexia nervosa potentially with follow-up for cancer across four decades. Thus, despite the
relatively young age at entry, a substantial number of cancers were observed in our study popu-
lation. The multinational assembly of the cohort provides opportunities to check for consisten-
cy of results across the populations in relation to frequent cancer outcomes such as overall
cancer and breast cancer. Relying on register-based information on exposure and outcome
tends to minimize bias. However, some less severe cases of anorexia nervosa are likely to have
been missed, since we did not include cases diagnosed in primary healthcare as well as cases di-
agnosed at out-patient visits in Denmark up until 1994, in Finland until 1997 and in Sweden
for the entire period. Thus, results cannot be generalized to all patients with anorexia nervosa.
We were able to adjust for reproductive variables that are important confounders for breast
cancer and gynecologic cancers, but unfortunately, we lacked information on other potential
confounders such as alcohol intake and physical activity. It should also be mentioned that an-
orexia nervosa does not match the carefully controlled circumstances in animal experiments of
energy restriction, e.g., the energy intake is often at the level of starvation and the need for es-
sential nutrients is not fulfilled in severe cases of anorexia nervosa.
Our study does not provide evidence to support that energy restriction reduces cancer oc-
currence among human beings as we found no general deficit of cancer across various cancer
sites in female patients with anorexia nervosa. A decreased risk was seen for female cancers, in
particular breast cancer, most likely as a consequence of low levels of estrogens. An increased
risk of some alcohol-related cancers such as esophageal and liver cancer was also present.
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